Relation Therapeutics
PrivateLast Round
Corporate Funding
Dec 9, 2025
Total Funding Raised
$76.33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Relation Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Strategic round in December 2024.
Relation Therapeutics is a biotechnology company that discovers and develops medicines by leveraging its proprietary 'Lab-in-the-Loop' platform which integrates active-graph machine learning, single-cell multi-omics, and genomic data derived from human patient tissue.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Relation Therapeutics Comparables
Compare Relation Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Therapeutics | 88% | |
| Terray Therapeutics | 86% | |
| BenevolentAI | 86% |
For institutional investors. Book with your work email.
Relation Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 9, 2025 | ||||
| Strategic | Dec 10, 2024 | ||||
| Seed Extension | Mar 14, 2024 | ||||
| Early Stage VC | Jan 9, 2024 | ||||
| Seed | Jun 9, 2022 | ||||
Seed | Jul 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Relation Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Corporate Funding, Seed Extension, Seed |
| Deerfield Management | Seed Extension |
| Firstminute Capital | Seed |
| Khosla Ventures | Seed, Seed Extension |
| Magnetic Ventures | Seed Extension, Corporate Funding, Seed |
| NVentures | Corporate Funding |
| The Bill & Melinda Gates Foundation Trust | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
PatchDNA model recognized at NeurIPS AI4D3 workshop.
- Jan 1, 2026
Initiated in 2026 to address fibrosis and osteoarthritis.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 14, 2026
Relation signs a collaboration with GSK valued at up to USD 110 million to develop AI-driven drug discovery models and human cellular datasets.
For institutional investors. Book with your work email.
Relation Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Relation Therapeutics's valuation, stock price, and market status.
Is Relation Therapeutics a public or private company?
Relation Therapeutics is a private company.
What is the current stock price of Relation Therapeutics?
Relation Therapeutics is a private company, so its shares have no public market price. Caplight tracks Relation Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Relation Therapeutics worth (valuation)?
Valuation information for Relation Therapeutics is not publicly available.
Can I buy Relation Therapeutics stock?
Relation Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Relation Therapeutics's last funding round?
Relation Therapeutics's most recent funding round was Corporate Funding on December 9, 2025.
Who are the main investors in Relation Therapeutics?
Key investors in Relation Therapeutics include Magnetic Ventures, Magnetic Ventures, NVentures, DCVC (Data Collective).
Will Relation Therapeutics IPO soon?
No public IPO plans have been announced for Relation Therapeutics.
How can I track Relation Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Relation Therapeutics's shares on secondary markets.